Skip to main content

Bath and Body Works (BBWI): Buy, Sell, or Hold Post Q4 Earnings?

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BBWI Cover Image

What a brutal six months it’s been for Bath and Body Works. The stock has dropped 22.6% and now trades at $16.28, rattling many shareholders. This might have investors contemplating their next move.

Is there a buying opportunity in Bath and Body Works, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Is Bath and Body Works Not Exciting?

Despite the more favorable entry price, we're cautious about Bath and Body Works. Here are three reasons there are better opportunities than BBWI and a stock we'd rather own.

1. Shrinking Same-Store Sales Indicate Waning Demand

Same-store sales show the change in sales for a retailer's e-commerce platform and brick-and-mortar shops that have existed for at least a year. This is a key performance indicator because it measures organic growth.

Bath and Body Works’s demand has been shrinking over the last two years as its same-store sales have averaged 1.8% annual declines.

Bath and Body Works Same-Store Sales Growth

2. Revenue Projections Show Stormy Skies Ahead

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Bath and Body Works’s revenue to drop by 2.9%. This projection is underwhelming and implies its products will face some demand challenges.

3. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for Bath and Body Works, its EPS and revenue declined by 2.6% and 1.2% annually over the last three years. In a mature sector such as consumer retail, we tend to steer our readers away from companies with falling EPS because it could imply changing secular trends and preferences. If the tide turns unexpectedly, Bath and Body Works’s low margin of safety could leave its stock price susceptible to large downswings.

Bath and Body Works Trailing 12-Month EPS (GAAP)

Final Judgment

Bath and Body Works isn’t a terrible business, but it doesn’t pass our bar. Following the recent decline, the stock trades at 6.5× forward P/E (or $16.28 per share). While this valuation is reasonable, we don’t really see a big opportunity at the moment. We're pretty confident there are more exciting stocks to buy at the moment. Let us point you toward a top digital advertising platform riding the creator economy.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  256.43
-8.44 (-3.18%)
AAPL  297.04
-0.80 (-0.27%)
AMD  410.17
-10.82 (-2.57%)
BAC  50.84
+0.16 (0.31%)
GOOG  384.75
-8.36 (-2.13%)
META  603.52
-7.69 (-1.26%)
MSFT  418.85
-4.69 (-1.11%)
NVDA  220.66
-1.66 (-0.75%)
ORCL  183.12
-3.49 (-1.87%)
TSLA  398.20
-11.79 (-2.88%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.